Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.
Video Forum: Christine Baeder, Teva USA
Latest
Ulta Beauty tops Wall Street expectations for third quarter
Beauty retailer raises its full-year outlook.
Focal Systems addresses grocery shrink
Theft Spotter alerts food retailers when specific items are stolen.
San Francisco files landmark lawsuit against ultra-processed food giants
The suit, filed in California Superior Court, names Kraft Heinz, Mondelez, Post, Coca-Cola, PepsiCo, General Mills, Nestlé, Kellanova, Kellogg, Mars, and ConAgra
Kroger delivers solid quarter despite $2.6 billion impairment
Gains in eCommerce and private-label brands offset charges tied to automated fulfillment network; grocer lifts earnings guidance for the year